Benchmark Research is a prominent clinical research firm that specializes in conducting investigational studies aimed at the development of new vaccines and medicines. With a history dating back to 1997, the company has successfully completed over 1,000 trials involving more than 40,000 participants. Their operations span multiple locations in California, Louisiana, and Texas, where they collaborate with both private and public sectors to ensure the safety and efficacy of new medical treatments. The firm focuses on a variety of areas, including acute care, allergy, general medicine, obesity, smoking cessation, vaccines, and women’s health, demonstrating a broad expertise in clinical research.

The company emphasizes the importance of participant involvement in clinical trials, offering individuals the opportunity to play an active role in their healthcare while contributing to medical research. Participants can access new treatments before they become widely available and are compensated for their time and efforts. Benchmark Research adheres to strict inclusion and exclusion criteria to ensure the safety of participants and the reliability of study results. The firm also prioritizes informed consent, ensuring that participants are fully aware of the study's purpose, procedures, and potential risks before enrolling. This commitment to ethical research practices underscores Benchmark Research's dedication to advancing medical science and improving public health outcomes.

United States

Benchmark Research, an Avacare business, has a track record of safety and expertise, having conducted more than 1,000 trials since 1997 at clinics located in California, Louisiana and Texas.

Benchmark's superior team of motivated and focused investigators offers clinical trials experience in a wide range of therapeutic areas. Our knowledgeable investigators enthusiastically embrace clinical research and the opportunities that new therapies bring to the marketplace and patients. Dedication and experience aside, our investigators are also highly trained in GCP and FDA regulations.

Benchmark Research

Company Details